You can buy or sell Mallinckrodt and other stocks, options, ETFs, and crypto commission-free!
MALLINCKRODT PUBLIC LIMITED COMPANY, also called Mallinckrodt, is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. Read More It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Staines-Upon-Thames, the United Kingdom.
52 Week High
52 Week Low
Mallinckrodt (MNK) Gains But Lags Market: What You Should Know
Mallinckrodt (MNK) closed the most recent trading day at $23.80, moving +0.59% from the previous trading session. This change lagged the S&P 500's 1.09% gain on the day. Elsewhere, the Dow gained 0.84%, while the tech-heavy Nasdaq added 1.42%. Heading into today, shares of the specialty pharmaceutical company had gained 11.5% over the past month, outpacing the Medical sector's gain of 1.58% and the S&P 500's gain of 1.18% in that time. Investors will be hoping for strength from MNK as it approaches its ne...
Mallinckrodt PLC Stock Quote (U.S.: NYSE)
Shares of drugmaker Mallinckrodt Plc were up 14% Tuesday morning after the British pharmaceutical company reported fourth-quarter earnings and revenue that soundly beat Wall Street expectations.
Expected May 7, Pre-Market